Clinical Trial Update: Endostar Combined With AI Regimen Compared With AI in Adjuvant Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing Endostar plus AI regimen versus AI alone as adjuvant treatment for soft tissue disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Other Disorders of Soft Tissues

Drugs mentioned

• AI regimen
• Endostar (recombinant human endostatin)

Snippet

Sponsor: Yong Chen | Conditions: Other Disorders of Soft Tissues | Phase 2 | Status: UNKNOWN